SCHEMBL7177356

SCHEMBL7177356

CC(C)Oc1ccc(C(C)C)cc1C=CC(=O)c1ccc(C(=O)N(C)C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.44
CXCL12 P48061 1/20 0.44
CAPN1 P07384 1/20 0.43
KDM4E B2RXH2 2/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
RAB9A P51151 1/20 0.42
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
PTPN1 P18031 2/20 0.41
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
AR P10275 1/20 0.39
CTSL P07711 2/20 0.38
CTSB P07858 2/20 0.38
SNCA P37840 1/20 0.38
TNFRSF1A P19438 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7188033 0.89 ABCG2 (0.57) ABCG2CXCL12CAPN1KDM4ELMNA
SCHEMBL7182953 0.87 ABCG2 (0.45) ABCG2CXCL12CAPN1KDM4ELMNA
SCHEMBL7180201 0.86 LMNA (0.49) ABCG2CXCL12CAPN1KDM4ELMNA
SCHEMBL7177412 0.85 DPP4 (0.46) ABCG2CXCL12CAPN1KDM4ELMNA
SCHEMBL7185759 0.84 ABCG2 (0.43) ABCG2CAPN1KDM4ELMNAMAPT
SCHEMBL7178602 0.84 PTPN1 (0.44) ABCG2CAPN1KDM4ELMNAMAPT
SCHEMBL7192165 0.84 ABCG2 (0.47) ABCG2CAPN1KDM4ELMNAMAPT
SCHEMBL7192169 0.84 ABCG2 (0.47) ABCG2CAPN1KDM4ELMNAMAPT
SCHEMBL9204172 0.83 MAPT (0.53) CAPN1LMNAMAPTRAB9APTPN1
SCHEMBL9204167 0.83 MAPT (0.53) CAPN1LMNAMAPTRAB9APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed